🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The goal of this prospective study is to explore the safety and preliminary...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center
Start Date
2025-01-15
Trial ID
NCT06775743
Treatments Being Tested
To improve the survival in patients with microsatellite stable metastatic c...
Status
Recruiting
Location
Fudan University
Start Date
2024-03-01
Trial ID
NCT06841159
Treatments Being Tested
This study is conducted to evaluate the efficacy, prognosis, adverse effect...
Status
Recruiting
Location
The Second Affiliated Hospital of Fujian Medical University
Start Date
2020-05-19
Trial ID
NCT05713994
To evaluate the safety and tolerability of IBI3005 combination therapy in p...
Status
Not Yet Recruiting
Location
SunYat-sen University Cancer Center
Start Date
2026-06-01
Trial ID
NCT07612137
Treatments Being Tested
The purpose of this prospective, randomized, multicenter, controlled clinic...
Status
Recruiting
Location
Sun Yat-sen University Cancer Center
Start Date
2026-05-15
Trial ID
NCT07594340
The purpose of this study is to evaluate the safety and efficacy of hepatic...
Status
Active Not Recruiting
Location
The first hospital of China medical university
Start Date
2024-08-16
Trial ID
NCT06632106
This study is a randomized, open-label, positive-controlled, multicenter ph...
Status
Recruiting
Location
West China Hospital of Sichuan University
Start Date
2024-10-24
Trial ID
NCT06558227
Treatments Being Tested
The goal of this study is to evaluate the efficacy and safety of multi-mode...
Status
Recruiting
Location
Shanghai Sixth People's Hospital
Start Date
2024-03-12
Trial ID
NCT06590259
Treatments Being Tested
Immune checkpoint inhibitors have a poor effect on MSS colorectal cancer. S...
Status
Unknown
Location
Xianglin Yuan
Start Date
2022-07-01
Trial ID
NCT05438108
Treatments Being Tested
Conversion therapy for unresectable intermediate-advanced hepatocellular ca...
Status
Recruiting
Location
Tianjin Cancer Hospital Airport Hospital
Start Date
2026-03-30
Trial ID
NCT07560488
Treatments Being Tested